Heart Test Laboratories Inc
NASDAQ:HSCS

Watchlist Manager
Heart Test Laboratories Inc Logo
Heart Test Laboratories Inc
NASDAQ:HSCS
Watchlist
Price: 2.68 USD 0.37% Market Closed
Market Cap: 7.1m USD
Section:
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

HSCS doesn't have a meaningful market cap.

The Relative Value of one HSCS stock under the Base Case scenario is 0.04 USD. Compared to the current market price of 2.68 USD, Heart Test Laboratories Inc is Overvalued by 98%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HSCS Relative Value
Base Case
0.04 USD
Overvaluation 98%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1 145.5
P/S
P/S
Price to Sales
1 145.5
vs History
60
vs Industry
2
Median 3Y
2 008.9
Median 5Y
2 095.9
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-4.6
Industry
22.5
Forward
-0.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4.6
Industry
14.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-3.8
Industry
21.6
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
46
vs Industry
47
Median 3Y
2.6
Median 5Y
2.6
Industry
2.2
More Details
695.1
EV/S
EV/S
Enterprise Value to Sales
695.1
vs History
60
vs Industry
0
Median 3Y
1 628.4
Median 5Y
1 846.3
Industry
2.6
More Details
1 197.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
1 197.2
vs History
60
vs Industry
0
Median 3Y
2 423
Median 5Y
3 249.6
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
54
Median 3Y
-3
Median 5Y
-3.8
Industry
12
Forward
-0.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
50
Median 3Y
-3
Median 5Y
-3.7
Industry
17
Forward
-0.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
54
Median 3Y
-3.1
Median 5Y
-3.5
Industry
14.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
44
Median 3Y
-3
Median 5Y
-3.5
Industry
18.7
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
78
vs Industry
86
Median 3Y
5.8
Median 5Y
6.8
Industry
1.9
More Details

Multiples Across Competitors

HSCS Competitors Multiples
Heart Test Laboratories Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Heart Test Laboratories Inc
NASDAQ:HSCS
7.1m USD 1 145.5 -0.8 -0.5 -0.5
US
Abbott Laboratories
NYSE:ABT
224.1B USD 5.1 16 20.4 28.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
205.6B USD 21.4 74.8 57.4 70
US
Boston Scientific Corp
NYSE:BSX
150.6B USD 7.8 53.9 31.4 42.7
US
Stryker Corp
NYSE:SYK
141.9B USD 5.8 48.2 23.5 28.4
IE
Medtronic PLC
NYSE:MDT
135B USD 3.9 28.3 15.8 22.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
60.2B USD 14.5 58.6 42.1 46.6
US
Becton Dickinson and Co
NYSE:BDX
55.6B USD 2.5 33.1 13.3 24.3
DE
Siemens Healthineers AG
XETRA:SHL
48B EUR 2.1 22.4 12.8 18
US
Edwards Lifesciences Corp
NYSE:EW
50.3B USD 8.6 36.8 26.3 28.9
US
Resmed Inc
NYSE:RMD
37.3B USD 7.1 26 18.6 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Heart Test Laboratories Inc
NASDAQ:HSCS
Average EV/EBITDA: 26.2
Negative Multiple: -0.5 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.4
13%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
57.4
25%
2.3
US
Boston Scientific Corp
NYSE:BSX
31.4
21%
1.5
US
Stryker Corp
NYSE:SYK
23.5
13%
1.8
IE
Medtronic PLC
NYSE:MDT
15.8
8%
2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.1
13%
3.2
US
Becton Dickinson and Co
NYSE:BDX
13.3
11%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
12.8
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
26.3
12%
2.2
US
Resmed Inc
NYSE:RMD
18.6
11%
1.7

See Also

Summary
HSCS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HSCS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HSCS stock valuation using valuation multiples.
Wall Street Estimates
HSCS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HSCS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 299,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.